Menu
Recruiting NCT04012658

A Registered Cohort Study on Wilson's Disease

Observational Wilson's Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: No intervention.
Who it may be relevant to
Registry conditions: Wilson's Disease. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The aim of this study is to determine the clinical spectrum and natural progression of Wilson's Disease in a prospective multicenter natural history study, to assess the clinical, genetic, epigenetic features and biomarkers of patients with Wilson's Disease to optimize clinical management.

Interventions

  • Other No intervention
    No intervention

Primary outcome measures

  • The change of Unified Wilson's Disease Rating Scale (UWDRS) [Time frame: Up to 30years]

Eligibility criteria

Inclusion criteria

  • Patients with the genetic diagnosis of Wilson's Disease
  • Asymptomatic Wilson's Disease carriers
  • Relatives of Wilson's Disease patients or carriers
  • Unrelated healthy controls
  • Participants or Parent(s)/legal guardian(s) willing and able to complete the informed consent process

Exclusion criteria

\* Participants are unable to comply with study procedures and visit schedule

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

China · 1 center
  • First Affiliated Hospital of Fujian Medical University — Fuzhou

Identifiers

NCT: NCT04012658 · MRCTA,ECFAH OF FMU[2019]197

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗